ECNP Precision Psychiatry Roadmap Initiative
|
We are pleased to highlight the publication of the flagship paper of our Precision Psychiatry Roadmap initiative in Molecular Psychiatry! This global initiative, co-ordinated by ECNP, calls for a shift from symptom-based classifications toward a precision psychiatry approach that integrates biological, behavioural, and symptomatic data. Through a biology-informed framework for mental disorders our vision is to see the right treatment for the right person at the right time.
|
|
|
ECNP Precision Psychiatry Roadmap Initiative
|
The Precision Psychiatry Roadmap podcast
|
In this Podcast episode, host Silvia Bruzzone, Denmark, is joined by Martien Kas, the Netherlands, and Hugh Marston, Germany, to discuss their just-released publication in Molecular Psychiatry: “Precision Psychiatry Roadmap: Towards a Biology-Informed Framework for Mental Disorders.”
|
|
|
|
According to the landmark ECNP-funded study just published in The Lancet Psychiatry, incorporating physical health into mental health care could save over €190 million annually in Europe. The study urges integrated care to reduce costly physical health issues tied to mental illness, improving outcomes and lowering hospital expenses across 32 European countries.
|
|
|
Join this new ECNP Course for cutting-edge insights into prevention and treatment strategies, organised by the ECNP Depression Meta Network.
Two learning tracks are available. The on-demand track contains expert lectures and knowledge tests, for which you can register anytime. The in-depth track includes everything in the on-demand track plus group assignments, live sessions with lecturers and an in-person colloquium on 10 October 2025 at the ECNP Congress in Amsterdam. In-depth track requires application before 3 July 2025 deadline.
|
|
|
|
This Mini-Course explores the multifaceted causes of panic disorder, including biological, psychological, and environmental factors. It also examines common comorbidities, such as depression and other anxiety disorders, as well as treatment approaches, including cognitive-behavioural therapy (CBT), pharmacotherapy with SSRIs or SNRIs, and emerging tools and mobile applications.
|
|
|
(Es)Ketamine treatment for depression
|
|
Andreas Reif, Germany, explores the paradigm shift in depression treatment with intranasal esketamine, the first NMDA antagonist antidepressant. The presentation concludes by outlining the challenges and ongoing trials of NMDA-based treatments, highlighting the potential of glutamate-system targeting for faster, more effective antidepressants in the future.
|
|
|
New Frontiers Meeting 2025
|
Selected recordings now available
|
Watch selected lectures from the 2025 New Frontiers Meeting which took place on 23-24 March 2025, in Nice, France, and virtually. Now available on the ECNP Knowledge Hub. The recorded lectures and discussions explore how circuit-based understandings of psychiatric illness are challenging traditional diagnostic classification and therapeutic specificity.
|
|
|
Book your Amsterdam accomodation now
|
If you have already registered to join #ECNP2025, secure your accommodation in Amsterdam now through our official housing agency, c’accomodation. See the preselected hotels with images, location, distance to the congress and more details. Beat the rush! |
|
|
If you want to unsubscribe, click here. |
|
|
|
|
